| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10918341 | Radiotherapy and Oncology | 2015 | 6 Pages |
Abstract
ProPED-LUNG is feasible with high compliance rates and yields a large amount of high quality prospective disease-related, treatment-related, patient- and physician-rated data which can be used to evaluate new developments in pulmonary radiotherapy.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Anne G.H. Niezink, Nienke J. Dollekamp, Harriet J. Elzinga, Denise Borger, Eduard J.H. Boer, Jan F. Ubbels, Marleen Woltman-van Iersel, Annija H.D. van der Leest, Max Beijert, Harry J.M. Groen, Jan Kraan, Thijo J.N. Hiltermann,